Skip to content
lifestyle.successxl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Amneal Pharmaceuticals LLC
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
June 4, 2026
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026
Amneal Reports First Quarter 2026 Financial Results
May 7, 2026
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
April 20, 2026
←
Previous Page
1
2